Evidence map›Paper›PMID 36454803›Full record

ArticlePloS one2022

The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy.

Hsiang-Chen Hsieh, Chun-Li Wang, Chuan-Shu Chen, Cheng-Kuang Yang, Jian-Ri Li, Shian-Shiang Wang, Chen-Li Cheng, Chia-Yen Lin, Kun-Yuan Chiu

Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07321210 (Clinical Efficacy and Safety of Radical Nephroureterectomy With Versus Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07321210 narecruitingnot on this mapstarted 2025, after this paper: background citation

Clinical Efficacy and Safety of Radical Nephroureterectomy With Versus Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma: A Multicenter, Prospective, Randomized Controlled Clinical Trial

TypeinterventionalSponsorTianjin Medical University Second HospitalRan2025 to 2032Enrolled150ConditionsUpper Tract Urothelial Carcinoma, Lymph Node DissectionArmsTemplate Lymph Node Dissection, Selective Lymph Node Resection
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hsiang-Chen HsiehDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.ORCID 0000-0002-2162-1282
Chun-Li WangInstitute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Chuan-Shu ChenDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Cheng-Kuang YangDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Jian-Ri LiDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Shian-Shiang WangDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Chen-Li ChengDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Chia-Yen LinDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.ORCID 0000-0002-6303-2187
Kun-Yuan ChiuDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate the prognostic impact of lymph node dissection (LND) in patients who underwent radical nephroureterectomy (RNU) with bladder cuff excision (BCE) for clinically node-negative (cN0) upper urinary tract urothelial carcinoma (UTUC).

methodsWe retrospectively enrolled 520 patients with cN0 UTUC in a single tertiary referral center from 2000 to 2015. The patients were divided into three groups: patients with and without pathologically proved lymph node metastasis (pN1-3 and pN0, respectively) and patients without LND (pNx). We analyzed associations between overall survival (OS)/ disease-free survival (DFS)/ cancer-specific survival (CSS) and clinical characteristics.

resultsThe patients were divided into three groups (pN1-3, pN0 and pNx with 20, 303, and 197 patients, respectively). OS/DFS/CSS in the pN1-3 group were significantly worse (all p<0.001) compared with the pN0 group. However, there were no significant differences between the pNx and pN0 groups. In the multivariate analyses, CSS was only affected by age [(hazard ratio (HR) = 1.03, p = 0.008]), positive surgical margin (HR = 3.38, p<0.001) and pathological T3-4 stages (HR = 4.07, p<0.001). In the subgroup analyses for patients with LND, locally advanced disease (pT3 and pT4) had significantly more metastases [T3-4: 13.91% (16/115) vs. T0-2: 1.92% (4/208), p<0.001].

conclusionsIn the pN0 group, LND for cN0 UTUC did not show therapeutic benefits in terms of DFS, CSS, and OS. However, LND with RNU allowed optimal tumor staging, through patients still had a poor prognosis. Clinically occult LN metastases were found in 6.2% of our patients.

Indexed as

Carcinoma, Transitional CellKidney NeoplasmsUreteral NeoplasmsUrinary Bladder NeoplasmsUrinary TractHumansLymph Node ExcisionNephroureterectomyPrognosisRetrospective Studies

Identifiers

PMID36454803
PMCPMC9714942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.